Literature DB >> 19074477

Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: is angiographic vasospasm an epiphenomenon?

Mervyn D I Vergouwen, Marinus Vermeulen, Yvo B W E M Roos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074477     DOI: 10.1161/STROKEAHA.108.537985

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  5 in total

1.  Cerebrospinal fluid 20-HETE is associated with delayed cerebral ischemia and poor outcomes after aneurysmal subarachnoid hemorrhage.

Authors:  Elizabeth A Crago; Bhavani P Thampatty; Paula R Sherwood; Chie-Wen J Kuo; Catherine Bender; Jeffrey Balzer; Michael Horowitz; Samuel M Poloyac
Journal:  Stroke       Date:  2011-05-26       Impact factor: 7.914

2.  Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage.

Authors:  Nora Sandow; Dominik Diesing; Asita Sarrafzadeh; Peter Vajkoczy; Stefan Wolf
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

3.  Plasma Estrogen Levels Are Associated With Severity of Injury and Outcomes After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Elizabeth A Crago; Paula R Sherwood; Catherine Bender; Jeffrey Balzer; Dianxu Ren; Samuel M Poloyac
Journal:  Biol Res Nurs       Date:  2014-12-29       Impact factor: 2.522

4.  SIRT1 mediates hypoxic postconditioning- and resveratrol-induced protection against functional connectivity deficits after subarachnoid hemorrhage.

Authors:  Julian V Clarke; Lindsey M Brier; Rachel M Rahn; Deepti Diwan; Jane Y Yuan; Annie R Bice; Shin-Ichiro Imai; Ananth K Vellimana; Joseph P Culver; Gregory J Zipfel
Journal:  J Cereb Blood Flow Metab       Date:  2022-02-09       Impact factor: 6.960

5.  The relationship between delayed infarcts and angiographic vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Robert J Brown; Abhay Kumar; Rajat Dhar; Tomoko R Sampson; Michael N Diringer
Journal:  Neurosurgery       Date:  2013-05       Impact factor: 4.654

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.